241 Stock Overview
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Alibaba Health Information Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.64 |
| 52 Week High | HK$5.88 |
| 52 Week Low | HK$2.60 |
| Beta | 1.02 |
| 1 Month Change | -24.79% |
| 3 Month Change | -18.01% |
| 1 Year Change | -53.77% |
| 3 Year Change | -88.27% |
| 5 Year Change | -72.27% |
| Change since IPO | -35.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| 241 | HK Consumer Retailing | HK Market | |
|---|---|---|---|
| 7D | -8.7% | -8.2% | -2.8% |
| 1Y | -53.8% | -59.5% | -15.0% |
Return vs Industry: 241 exceeded the Hong Kong Consumer Retailing industry which returned -59.6% over the past year.
Return vs Market: 241 underperformed the Hong Kong Market which returned -16.4% over the past year.
Price Volatility
| 241 volatility | |
|---|---|
| 241 Average Weekly Movement | 7.5% |
| Consumer Retailing Industry Average Movement | 8.6% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.8% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 241's share price has been volatile over the past 3 months.
Volatility Over Time: 241's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,547 | Difan Shen | www.alihealth.cn |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, adult and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and traditional Chinese medicine through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, AMap, Freshippo, DingTalk, and Quark.
Alibaba Health Information Technology Limited Fundamentals Summary
| 241 fundamental statistics | |
|---|---|
| Market cap | HK$42.45b |
| Earnings (TTM) | HK$884.08m |
| Revenue (TTM) | HK$30.53b |
48.0x
P/E Ratio1.4x
P/S RatioIs 241 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 241 income statement (TTM) | |
|---|---|
| Revenue | CN¥28.22b |
| Cost of Revenue | CN¥21.95b |
| Gross Profit | CN¥6.27b |
| Other Expenses | CN¥5.45b |
| Earnings | CN¥817.10m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.051 |
| Gross Margin | 22.22% |
| Net Profit Margin | 2.90% |
| Debt/Equity Ratio | 0% |
How did 241 perform over the long term?
See historical performance and comparison